Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-24.10	18.88	24.88
Graham Fair Price	14.05	8906.64	7809.25
PEG	96.53	0.23	-0.12
Price/Book	-2.35	0.38	0.39
Price/Cash Flow	-41.25	-8.15	13.88
Prices/Earnings	-20.16	5.96	7.47
Price/Sales	1.89	0.72	0.70
Price/FCF	-41.25	-8.15	13.88
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-5.78	0.17	0.18
Operating Margin	81.87	0.06	0.04
ROA	18.99	< 0.005	< 0.005
ROE	0.01	0.02	22.31
ROIC	0.01	0.01	-2.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	-0.02	75.88
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.58	0.72	23.80
EPS QOQ	-0.64	0.26	-59.38
FCF QOQ	18.17	-2.64	-85.45
Revenue QOQ	0.05	-0.05	12.31
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	98.32	101.98	3.72
Days Sales Outstanding (DSO)	59.13	65.04	9.99
Inventory Turnover	0.92	0.88	-3.59
Debt/Capitalization	0.54	0.55	2.23
Quick Ratio	0.47	0.47	-0.52
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	14331.27	14779.51	3.13
Cash	3851.16	4382.78	13.80
Capex	-391.04	-830.24	-112.31
Free Cash Flow	407.12	-697.84	71.41
Revenue	8045.84	7952.15	-1.16
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.86	0.83	-3.54
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.59	13.61	-22.61
Naive Interpretation	Member

06 - Financial Health · Bad

Rating